Cigarette smoking during pregnancy has been shown to increase the incidence of abortions, premature deliveries and lighter weight of the newborns. However, an explicit explanation for these findings is still lacking and until now it cannot be excluded that the constitution of the pregnant woman who smokes might be related to these observations and not to the smoking habit per se [2, 5, 11, 24, 32, 33] . Besides these clinical findings it was demonstrated that in the term placenta the enzymatic hydroxylation of benzo(a)pyrene (BP), one of several carcinogens present in cigarette smoke, was found in almost all placentas from women with smoking habits during pregnancy but no or only little BP hydroxylase could be detected in the placentas from nonsmokers [13, 29, 30] . The relationship of the clinical findings and the ability of components of cigarette smoke to stimulate BP hydroxylation by enzymes in the placenta still remains to be clarified. The results of these studies have prompted our laboratory in late 1970 to evaluate whether in the immature placenta BP hydroxylase activity could be detected and whether there exists a correlation between the activity of this enzyme and the habit of cigarette smoking during the early phase of pregnancy. Since then, data were published showing that in the immature placenta the capacity to metabolize BP was not found in the placentas from nonsmokers, but the placentas from smokers metabolized BP, though being lower in the immature than in the term tissue. However, no enzyme activity was detectable in the placenta from smokers before the eleventh week of pregnancy [7, 19] . Similarly, in rats the maximum stimulatory effect by BP treatment on BP hydroxylase in the placenta was not achieved before day 15 of gestation [26, 27] . Besides the above mentioned data, the capacity of enzymes in the human placenta to metabolize drugs and foreign compounds is rather limited. Immature or mature placentas were inactive in metabolizing hexobarbital, chlorpromazine, codein, aniline, aminopyrine, amphetamine, p-nitrobenzoic acid [8], p-nitroanisole, acetaniline, amphetamine, aniline [3], phenobarbital [29] though N-methylaniline [20] and neoprontisil [8] were found to be metabolized and 3-methyl-4-monomethylamino-*) This work was supported by a grant of the Deutsche Forschungsgemeinschaft given to the Sonderforschungsbereich 29, "Embryonale Entwicklung und Differenzierung (Embryonal-Pharmakologie)".
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l Materials and methods
Tissues:
Placenta and fetal liver were obtained from patients undergoing therapeutic abortion for socio-medical reasons. All patients received the following premedication and anesthesia: Cyclobarbital, 100mg; isothipendyl, 20mg; fentanyl citrate, 0.10 mg; droperidol, 5.0 mg; atropin, 0.25 mg; succinyldicholine, 100-200 mg; thiopental, 150 mg; and halothane, nitrous oxide, oxygen, and 300-500 ml of a plasma expander and 300-500 ml of a 5% glucose solution. Clinical histories were recorded by staff members of the hospital while one author (E. S.) asked the women for smoking habits during pregnancy. The duration of pregnancy was estimated from the last menstrual period. All patients lived in Berlin. Tissues were obtained from 5 patients by hysterotomy and from 13 patients by curettage. The tissues obtained during surgery were immediately frozen in liquid nitrogen and stored in liquid nitrogen until use within l-5 days. The tissues were than thawed at room temperature. Two 8 gram samples of one placenta were dissected from connective tissue. The placenta was carefully minced and homogenized in ice cold 0.32 M sucrose-tris HC1 solution (0.01 M tris HC1, pH 7.4). The whole fetal liver was homogeiaized in the same solution. Only whole homogenates were employed for the enzyme assays.
Enzyme assays:
The following incubation mixturewas used for the measurement of benzo(a)pyrene hydroxylase activity: 5 enzyme units of glucose-6-phosphate dehydrogenase in 0.05 M tris HC1 bufFer (pH 7.4); glucose-6-phosphate in 0.05 M tris HC1 bufFer (pH 7.4), 6,5 ^moles; nicotine adenine dinucleotide phosphate (NADP), 0.5//moles; nicotine adenine dinucleotide (NAD), O.o^moles; ädenosine triphosphate (ATP), 2.01 /jmoles; NADP, NAD, and ATP were dissolved in 0.1 M KH 2 PO 4 -K 2 HPO 4 bufFer (pH 7.4), nicotinamide, 12^moles; KC1, 200ywmoles; MgQ 2 , 10/imoles; 1.0ml KHgPO^igHPC^ bufFer (pH 7.4), benzo(a)pyrene 6.39 X 10~5 M dissolved in 0.1 ml acetone, and 0.5 ml of placental homogenate equivalent 100-200 rng wet weight or 0.5 ml fetal liver homogenate equivalent 10-20 mg wet weight. The total volume was 3.1 ml. Placental homogenates were incubated for 20 min at 37°C and liver homogenates for 10 min at 37°C. For the measurement of ethylmorphine N^demethyläse each incubation flask consisted of the following: 3 enzyme units of glucose-6-phosphate dehydrogenase, glucose-6-phosphate, 20/«noles; NADP, 2//moles; nicotinamide, 20/zmoles; MgQ 2 , lO^moles; semicarbacide HO, 37.5 moles; KH 2 PO 4 -Na 2 HPO 4 bufFer, pH 7.4, 200^moles; 1.0 ml of fetal liver homogenate equivalent to 400 mg wet weight; ethyl-morphine, 2 10~3 M dissolved in 1.0ml 1.15% KC1, and 1.15% KC1 solution to give a final volume of 5.0 ml. The reaction mixtures were incubated for 15 min at 37°C. For each enzyme assay two blanks were employed. One blank was incubated with the complete reaction mixture but without the homogenate and with the Substrate. A second blank was incubated with the homogenate but without the Substrate. Under these experimental conditions enzyme activities were linear.
Analytical procedutes:
Benzo(a)pyrene hydroxylase activity was assayed äs detailed previously [9, 28] . The hydroxylated metabolite(s) of benzo(a)pyrene produced during the incubation was measured with a ZEISS fluorometer, using 3-hydroxybenzo(a)pyrene äs a reference. Ethylmorphine N-demethylase activity was measured by the NASH procedure [12] äs described in the literature [1] with the exception that 1.0ml 50% trichloroacetic acid was added to stop the reaction.
Results

Enzymatic hydroxylation of benzo(a)-
pyrene in the placenta The hydroxylation rate o£ benzo(a)pyrene was measured in the placentas obtained from 9 nonsmokers and from 9 smokers. In both groups the mean gestational age did not vary consid- In the placentas from 9 smokers in 3 no metabolism of BP was found (patients R. A., D. M., R. J.). These women smoked 3 to 4 or more than 10 cigarettes daily. In the other 6 placentas the rate of BP hydroxylation varied and no corre-lation was found between the daily number of different. In addition, in our experiments the cigarettes smoked and the level of BP hydroxylase immediate storage of the placenta in liquid activity. In this group the mean BP hydroxylase nitrogen may prevent the degradation of a labile activity was 0.344 i 0.413/jg 3-Hydroxy-BP/g form of BP hydroxylase. b) The women of the tissue/hr. nonsmoking group might have been exposed to In three placentas obtained during the eleventh foreign compounds or drugs that resulted in week of pregnancy (from nonsmokers E. S. and elevated levels of BP hydroxylase activity. from smokers G. G. and X. G.) BP hydroxylase Interestingly, the highest enzyme activity is found activity was detectable.
in the placenta of nonsmoker C. D. who was With the exception of placentas from non-taking high doses of drugs. Some of these drugs smokers C. D. and H. M. and from smokers (barbiturates and probably aminophenazone) do B. D. and R. S. the rate of BP hydroxylation was stimulate various drug metabolizing enzyme not identical in the two samples of one placenta reactions in man [4] . However, it h s not been examined. This indicates that this enzyme might established that they enhaiice the hydroxylation be predominantly localized in distinct areas of the of BP. c) Other factors involved may be genetic t placenta.
differences in the capacity to metabolize BP and furthermore variations in the living conditions.
The disproportionate distribution of this enzyme pyrene and enzymatic N-demethylation found in our expenments indicates a distmct of ethylmorphine in the fetal liver loca zation within differentiated parts o£ the _,, r i r τ · ι r o placenta. Recently, regional differences in the The age of the fetuses obtained from 3 non-.,,. , to protect fetal tissues susceptible to the cytotoxic The results presented in this paper do not effects of these compounds [14] . demonstrate differences in the levels of BP In conclusion, more work is needed to evaluate hydroxylase activity in the placenta obtained the relevance of the drug metabolizing capacity from nonsmoking and cigarette smoking of fetal tissues, including the placenta. In addition, women between the eleventh and nineteenth alterations in maternal drug metabolism may week of pregnancy. This might suggest that occur in those women who are ' exposed to components of cigarette smoke have no or only chronic drug administration during pregnancy a small stimulatory effect on the BP hydroxylation and thus might affect fetal development. Under rate during this phase of placental development. experimental conditions, chronic phenobarbital The differences between our results and those treatment of pregnant rats showed markedly reported in the literature [6, 19] can be related decreased drug metabolizing enzyme activity when to the following factors: a) The methods used for compared with nonpregnant phenobarbital treated measuring BP hydroxylase activity were slightly rats [25] . Summary Benzo(a)pyrene (BP) hydroxylase activity was assayed in the immature placenta obtained from 9 nonsmoking and from 9 cigarette smoking women undergoing therapeutic abortion for socio-medical reasons between the eleventh and nineteenth week of pregnancy. In the nonsmoking group the activity o£ this enzyme was not detectable in 4 placentas. In the other 5 placentas the hydroxylation rate of BP ranged from 0.088 to 1.510//g 3-Hydroxy-BP/g tissue/h (Tab. I). In the placentas obtained from 9 women with a history of cigarette smoking 3 had no BP hydroxylase activity. These women smoked 3 to 20 cigarettes daily. The other 6 women smoked almost the same daily number of cigarettes and in the placentas of these individuals the rate of BP hydroxylation ranged from 0.068 to 1.176//g 3-Hydroxy-BP/g tissue/h. The mean ± S. D. of BP hydroxylase activity was 0.252 ± 0.489 and 0.345 ± 0.413 /*g 3-Hydroxy-BP/g tissue/h in the nonsmoking and cigarette smoking group, respectively. These data suggest that between the eleventh and nineteenth week of pregnancy cigarette smoke has no or only a small stimulatory effect on placental BP hydroxylase activity. Furthermore, other factors than components of cigarette smoke might enhance enzymatic BP hydroxylation. For example, the highest enzyme activity (1.510^g 3-Hydroxy-BP/g tissue/h) was found in the placenta of a nonsmoker who was taking high doses of barbiturates and other drugs. -The disproportionate distribution of this enzyme found in our experiments indicates a distinct localization within difTerentiated parts of the placenta. In the fetal liver the activity of enzymes that hydroxylate BP and N-demethylate ethylmorphine was demonstrated. No correlation was observed between the levels of BP hydroxylase activity in the fetal liver and in the placenta. In fetal tissues the capacity to metabolize drugs and foreign compounds does not necessarily imply a detoxification mechanism since metabolites derived from these reactions might be harmful for the rapidly proliferating and differentiating fetal tissues.
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